Evidence map›Paper›PMID 38768632›Full record

ArticleNature2024

In vitro reconstitution of epigenetic reprogramming in the human germ line.

Yusuke Murase, Ryuta Yokogawa, Yukihiro Yabuta, Masahiro Nagano, Yoshitaka Katou, Manami Mizuyama, Ayaka Kitamura, Pimpitcha Puangsricharoen, Chika Yamashiro, Bo Hu and 6 more

Abstract read
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Solones, Solo Reproduction and Vice.Asian bioethics review · 2026
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Mechanisms of human germ cell development.Nature reviews. Molecular cell biology · 2026
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Yusuke Murase *Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Ryuta Yokogawa *Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.ORCID 0000-0002-7033-2794
Yukihiro YabutaInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Masahiro NaganoInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Yoshitaka KatouInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Manami MizuyamaInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.ORCID 0009-0003-3971-2996
Ayaka KitamuraInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Pimpitcha PuangsricharoenInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Chika YamashiroDepartment of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0001-7412-6341
Bo HuInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Ken MizutaInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.ORCID 0000-0002-3922-1009
Taro TsujimuraInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Takuya YamamotoInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Kosuke OgataDepartment of Molecular Systems BioAnalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.ORCID 0000-0002-0634-3990
Yasushi IshihamaDepartment of Molecular Systems BioAnalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.ORCID 0000-0001-7714-203X
Mitinori SaitouInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan. saitou@anat2.med.kyoto-u.ac.jp.ORCID 0000-0002-2895-6798

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epigenetic reprogramming resets parental epigenetic memories and differentiates primordial germ cells (PGCs) into mitotic pro-spermatogonia or oogonia. This process ensures sexually dimorphic germ cell development for totipotency

Indexed as

Cellular ReprogrammingEpigenesis, GeneticGerm CellsIn Vitro TechniquesAmnionBone Morphogenetic ProteinsDNA MethylationFemaleGene Expression Regulation, DevelopmentalHumansMaleMAP Kinase Signaling SystemMitosisMixed Function OxygenasesOogenesisOogoniaBone Morphogenetic ProteinsMixed Function OxygenasesProto-Oncogene ProteinsTET1 protein, human

Identifiers

PMID38768632
PMCPMC11222161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.